Evidence map›Paper›PMID 40162420›Full record

ArticleWorld journal of gastrointestinal surgery2025

High cellular prion protein expression in cholangiocarcinoma: A marker for early postoperative recurrence and unfavorable prognosis.

Dong Woo Shin, Yoon Ah Cho, Sung-Hoon Moon, Tae Hyung Kim, Ji-Won Park, Jung-Woo Lee, Ji-Young Choe, Min-Jeong Kim, Sung-Eun Kim

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dong Woo ShinDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Gyeonggi-do, South Korea.
Yoon Ah ChoDepartment of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea.
Sung-Hoon MoonDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Gyeonggi-do, South Korea.
Tae Hyung KimDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Gyeonggi-do, South Korea.
Ji-Won ParkDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Gyeonggi-do, South Korea.
Jung-Woo LeeDepartment of Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, South Korea.
Ji-Young ChoeAnatomic Pathology Reference Lab, Seegene Medical Foundation, Seoul 04805, South Korea.
Min-Jeong KimDepartment of Radiology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, South Korea.
Sung-Eun KimDepartment of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Gyeonggi-do, South Korea. sekim@hallym.or.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe cellular prion protein (PrP

aimTo investigate the influence of PrP

methodsPatients who underwent curative surgical resection for either intrahepatic or hilar CCA were enrolled in this retrospective study. Based on the immunohistochemical staining results of the surgical specimens, patients were categorized into two groups: The low PrP

resultsIn total, seventy-six patients diagnosed with CCA (39 with intrahepatic and 37 with hilar CCA) underwent curative hepatectomy from January 2011 to November 2021. Among these patients, 38 (50%) demonstrated high PrP

conclusionPrP

Indexed as

Cellular prion proteinCholangiocarcinomaLiver neoplasmsPrognosisRecurrenceSurvival

Identifiers

PMID40162420
PMCPMC11948104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.